1[1]Davi G,Patrono C.Platelet activation and atherothrombosis[J].N Engl J Med,2007,357(24):2482-2494.
2[2]Schwartz SM,Galis ZS,Rosenfeld ME,et al.Plaque rupture in humans and mice[J].Arterioseler Thromb Vase Biol,2007,27(4):705-713.
3[3]Lafont A,Brasselet C.Plaque vulnerability:mechanisms and detection.In:MarcoJ,Serruys P,Biamino G,et al (eds).The Paris Course on Revaseularization,2003,41-51.
4[4]Mauri L,Hsieh W,Massaro JM,et al.Stent thrombosis in randomized clinical trials of drug-eluting stents[J].N Engl J Med,2007,356(10):1029-1029.
5[5]Steffel J,Luscher TF,Tanner FC.Tissue factor in cardiovascular diseases:molecular mechanisms and clinical implications[J].Circulation,2006,113(5):722-731.
6[6]Hodgson JM,Stone GW,Michael Lincoff A,et al.Late stent thrombosis:Considerations and practical advice for the use of drug-eluting stents:A report from the Society for Cardiovascular Angiography and Interventions drug-e-luting stent task force[J].Catheter Cardiovasc Interv,2007,6 (3):327-333.
7[7]Joner M,Finn AV,Farb A,et al.Pathology of drug-elu-ting stents in humans:delayed healing and late thrombotic risk[J].J Am CoIl Cardiol,2006,48(1):193-202.
8[8]Cutlip D.Report presented at TCT on October 25,2006[EB/OL].(2006-12-13).Medscape.Com/ viewarticle/546575.
9[9]Katayama T,Yamamoto T,Iwasaki Y,et al.Two cases of very late stent thrombosis after implantation of a siroli-mus-eluting stent presenting as AMI[J].Int Heart J,2007,48(3):393-397.
10[10]Bavry AA,Bhatt DL.Drug-eluting stents:dual antiplateet therapy for every survivor?[J].Circulation,2007,116(7):696-699.
